Observational Study of Serratus Anterior Plane Block (SAPB) for Rib Fractures
This study is looking at how a pain treatment called the serratus anterior plane block (SAPB) affects adults with multiple rib fractures on one side of their body. The SAPB is a type of regional anesthesia, meaning it numbs a specific area to help with pain. Researchers want to see if SAPB, when given within 24 hours of injury, can reduce problems like pneumonia (a lung infection), shorten how long people stay in the hospital, and improve their overall recovery and survival, compared to standard pain medicines. You might be able to join if you are over 18, have at least two rib fractures on one side, and are being treated in the Emergency Department at Jacobi Medical Center within 24 hours of your injury. The study is currently observational, meaning researchers will watch and collect information, but the recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will collect information about patients' experiences. It plans to include about 220 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed from their emergency department arrival until hospital discharge, and up to 90 days after injury, to track outcomes like pneumonia, hospital stay, and discharge plans.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Assessment of Morbidity and Mortality Following Serratus Anterior Plane Block (SAPB) for Unilateral Rib Fractures
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michelle Montenegro, MD · PRINCIPAL_INVESTIGATOR · Albert Einstein College of Medicine, Jacobi medical center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of Patients with Hospital Acquired Pneumonia (HAP) EventsFrom time of ED arrival until hospital discharge, up until 90 days
The number of patients of hospital acquired pneumonia events will be summarized by study arm/group using basic descriptive statistics.
- Days of Hospital Length of StayED arrival to hospital discharge, up until 90 days
For purposes of this study, length of hospital stay will be defined as the total duration of admission and will be recorded in total number of days (from ED admission to discharge) and summarized by study arm/group using basic descriptive statistics. Discharge may include to acute rehabilitation (located in the hospital but not considered in calculation for length of stay).
- Discharge DispositionED admission to discharge , up until 90 days
Discharge Disposition will encompass the location to which the patient is discharged (i.e., home, home with Physical Therapy (PT), subacute rehabilitation, acute rehabilitation, or deceased). Disposition types will be categorically itemized and summarized by study arm/group.
- Length of stay (Days) in the Intensive Care Unit (ICU)ED admission to hospital discharge, up until 90 days
For purposes of this study, ICU length of stay will be defined as the total number of days of admission to an ICU and will be summarized by study arm/group using basic descriptive statistics. If a patient is discharged from the ICU and subsequently returns to the ICU, the total duration of admission will be aggregated.
- Cause of deathED admission until hospital discharge, up until 90 days
If a patient is "discharged as deceased" (see prior outcome measure) the cause of death will be recorded, if known, and summarized by study arm/group.